UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

   

 


 

FORM 8-K 

    


 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

June 18, 2020

Date of report (Date of earliest event reported)

 

GENPREX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

001-38244

90 - 0772347

(State or other jurisdiction of

incorporation)

(Commission File Number)

(I.R.S. Employer

Identification Number)

 

 

 

1601 Trinity Street, Suite 3.312.09, Austin, TX

 

78712

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (512) 537-7997

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

GNPX

 

The Nasdaq Capital Market

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒


 

 

 

 

Item 5.07: Submission of Matters to a Vote of Security Holders.

 

On June 18, 2020, the Company held its 2020 Annual Meeting of Stockholders (the “Annual Meeting”). As of April 20, 2020, the record date for the Annual Meeting, 32,854,841 shares of the Company’s common stock were outstanding and entitled to vote at the Annual Meeting. A summary of the matters voted upon by stockholders at the Annual Meeting is set forth below.

 

A total of 21,121,645 shares of the Company’s common stock were present at the meeting in person or by proxy, which represents approximately 64.29% of the shares of common stock outstanding as of the record date for the Annual Meeting.

 

Proposal 1. Election of Directors.

 

The Company’s stockholders elected the persons listed below as Class III Directors, each to serve until the Company’s 2023 Annual Meeting of Stockholders and until his successor is duly elected and qualified. The final voting results are as follows:

 

 

Name

  

Votes For

  

Votes Withheld

  

Broker Non-Votes

Jose A. Moreno Toscano

  

6,165,114

  

63,079

  

14,893,452

J. Rodney Varner   5,854,575   373,618   14,893,452

 

Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm.

 

The Company’s stockholders ratified the selection of Daszkal Bolton LLP by the Audit Committee of the Company’s Board of Directors as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020. The final voting results are as follows:

 

 

Votes For

  

Votes Against

  

Abstention

  

Broker Non-Votes

20,756,998

  

180,046

  

184,601

  

0

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

GENPREX, INC.

 

 

 

 

 

Date: June 23, 2020

By:

/s/ Ryan Confer

 

 

 

Ryan Confer

 

 

 

Chief Financial Officer

(Principal Financial Officer)

 

 

 
Genprex (NASDAQ:GNPX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Genprex Charts.
Genprex (NASDAQ:GNPX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Genprex Charts.